Mereo Biopharma Stock Steadies Premarket as Jpm Healthcare Conference Puts Mreo Back in Play
Mereo BioPharma stock steadies premarket as key JPM Healthcare Conference presentation sets the stage for future growth. CEO to discuss challenges & opportun…